Therapeutic Potential of Orally Administered Rubiscolin-6.

导出 OA

翻译打印收藏纠错

作者： Yusuke,Karasawa ^[1] ; Kanako,Miyano ^[2] ; Masahiro,Yamaguchi ^[3] ; Miki,Nonaka ^[1] ; Keisuke,Yamaguchi ^[2] ; Masako,Iseki ^[4] ; Izumi,Kawagoe ^[1] ; Yasuhito,Uezono ^[2]

作者单位： Department of Pain Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan. ^[1] Department of Pain Control Research, The Jikei University School of Medicine, Tokyo 105-8461, Japan. ^[2] Medical Affairs, Viatris Pharmaceuticals Japan Inc., Tokyo 105-0001, Japan. ^[3] Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. ^[4] Medical Affairs, Pfizer Japan Inc., Tokyo 151-8589, Japan. ^[5] Department of Anesthesiology and Pain Medicine, Faculty of Medicine, Juntendo University, Tokyo 113-8421, Japan. ^[6] Supportive and Palliative Care Research Support Office, National Cancer Center Hospital East, Chiba 277-8577, Japan. ^[7]

关键词 delta-opioid receptor opioid peptide rubiscolin spinach

主题词核酮糖二磷酸羧化酶(Ribulose-Bisphosphate Carboxylase);受体, 阿片样, δ(Receptors, Opioid, delta);寡肽类(Oligopeptides);阿片样肽类(Opioid Peptides)

DOI 10.3390/ijms24129959

PMID 37373107

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交